nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A3—Metformin—metabolic syndrome X	0.352	0.475	CbGbCtD
Phenoxybenzamine—SLC22A2—Metformin—metabolic syndrome X	0.209	0.281	CbGbCtD
Phenoxybenzamine—SLC22A1—Metformin—metabolic syndrome X	0.181	0.244	CbGbCtD
Phenoxybenzamine—CALM1—sympathetic nervous system—metabolic syndrome X	0.0106	0.145	CbGeAlD
Phenoxybenzamine—CALM1—autonomic nervous system—metabolic syndrome X	0.00712	0.0974	CbGeAlD
Phenoxybenzamine—Gastrointestinal tract irritation—Metformin—metabolic syndrome X	0.00652	0.497	CcSEcCtD
Phenoxybenzamine—CALM2—artery—metabolic syndrome X	0.00405	0.0555	CbGeAlD
Phenoxybenzamine—CALM1—artery—metabolic syndrome X	0.00404	0.0552	CbGeAlD
Phenoxybenzamine—CALM2—endothelium—metabolic syndrome X	0.00343	0.0469	CbGeAlD
Phenoxybenzamine—CALM1—endothelium—metabolic syndrome X	0.00341	0.0466	CbGeAlD
Phenoxybenzamine—CALM2—blood vessel—metabolic syndrome X	0.00316	0.0432	CbGeAlD
Phenoxybenzamine—CALM1—blood vessel—metabolic syndrome X	0.00314	0.043	CbGeAlD
Phenoxybenzamine—SLC22A2—kidney—metabolic syndrome X	0.0024	0.0329	CbGeAlD
Phenoxybenzamine—ADRA1B—kidney—metabolic syndrome X	0.0023	0.0315	CbGeAlD
Phenoxybenzamine—Nasal congestion—Metformin—metabolic syndrome X	0.00186	0.141	CcSEcCtD
Phenoxybenzamine—Tamoxifen—FMO3—metabolic syndrome X	0.00184	0.523	CrCbGaD
Phenoxybenzamine—SLC22A1—kidney—metabolic syndrome X	0.0017	0.0232	CbGeAlD
Phenoxybenzamine—SLC22A3—kidney—metabolic syndrome X	0.00162	0.0222	CbGeAlD
Phenoxybenzamine—CALM3—adipose tissue—metabolic syndrome X	0.00158	0.0216	CbGeAlD
Phenoxybenzamine—SLC22A1—adipose tissue—metabolic syndrome X	0.00153	0.0209	CbGeAlD
Phenoxybenzamine—SLC22A3—adipose tissue—metabolic syndrome X	0.00146	0.02	CbGeAlD
Phenoxybenzamine—CALM2—cardiovascular system—metabolic syndrome X	0.00141	0.0193	CbGeAlD
Phenoxybenzamine—CALM1—cardiovascular system—metabolic syndrome X	0.0014	0.0192	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Metformin—metabolic syndrome X	0.0014	0.107	CcSEcCtD
Phenoxybenzamine—CALM2—kidney—metabolic syndrome X	0.00138	0.0189	CbGeAlD
Phenoxybenzamine—CALM1—kidney—metabolic syndrome X	0.00137	0.0188	CbGeAlD
Phenoxybenzamine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00132	0.0181	CbGeAlD
Phenoxybenzamine—Drowsiness—Metformin—metabolic syndrome X	0.0013	0.0992	CcSEcCtD
Phenoxybenzamine—CALM2—adipose tissue—metabolic syndrome X	0.00124	0.017	CbGeAlD
Phenoxybenzamine—CALM1—adipose tissue—metabolic syndrome X	0.00124	0.0169	CbGeAlD
Phenoxybenzamine—ADRA2C—kidney—metabolic syndrome X	0.00123	0.0169	CbGeAlD
Phenoxybenzamine—ADRA1A—adipose tissue—metabolic syndrome X	0.00117	0.0159	CbGeAlD
Phenoxybenzamine—ADRA2C—adipose tissue—metabolic syndrome X	0.00111	0.0152	CbGeAlD
Phenoxybenzamine—CALM3—liver—metabolic syndrome X	0.00111	0.0152	CbGeAlD
Phenoxybenzamine—SLC22A1—liver—metabolic syndrome X	0.00107	0.0147	CbGeAlD
Phenoxybenzamine—SLC22A3—liver—metabolic syndrome X	0.00103	0.014	CbGeAlD
Phenoxybenzamine—ADRA2A—adipose tissue—metabolic syndrome X	0.000886	0.0121	CbGeAlD
Phenoxybenzamine—CALM2—liver—metabolic syndrome X	0.000871	0.0119	CbGeAlD
Phenoxybenzamine—CALM1—liver—metabolic syndrome X	0.000867	0.0119	CbGeAlD
Phenoxybenzamine—ADRA1A—liver—metabolic syndrome X	0.000817	0.0112	CbGeAlD
Phenoxybenzamine—ADRA2C—liver—metabolic syndrome X	0.000779	0.0107	CbGeAlD
Phenoxybenzamine—CYP3A4—kidney—metabolic syndrome X	0.000774	0.0106	CbGeAlD
Phenoxybenzamine—Somnolence—Metformin—metabolic syndrome X	0.000739	0.0563	CcSEcCtD
Phenoxybenzamine—Fatigue—Metformin—metabolic syndrome X	0.000716	0.0546	CcSEcCtD
Phenoxybenzamine—Asthenia—Metformin—metabolic syndrome X	0.000596	0.0454	CcSEcCtD
Phenoxybenzamine—CYP3A4—liver—metabolic syndrome X	0.000489	0.00669	CbGeAlD
Phenoxybenzamine—Atomoxetine—HTR2C—metabolic syndrome X	0.000486	0.139	CrCbGaD
Phenoxybenzamine—Fenoprofen—PTGS2—metabolic syndrome X	0.000441	0.126	CrCbGaD
Phenoxybenzamine—Fenoprofen—ALB—metabolic syndrome X	0.000393	0.112	CrCbGaD
Phenoxybenzamine—Phenylbutazone—PTGS2—metabolic syndrome X	0.000353	0.101	CrCbGaD
Phenoxybenzamine—CALM3—Disease—INS—metabolic syndrome X	1.57e-05	9.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PPARA—metabolic syndrome X	1.57e-05	9.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PPARA—metabolic syndrome X	1.57e-05	9.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.57e-05	9.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.56e-05	9.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-05	9.3e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ALB—metabolic syndrome X	1.56e-05	9.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.56e-05	9.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOB—metabolic syndrome X	1.55e-05	9.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOB—metabolic syndrome X	1.55e-05	9.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.55e-05	9.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.55e-05	9.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.54e-05	9.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.54e-05	9.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—APOE—metabolic syndrome X	1.54e-05	9.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.54e-05	9.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—LPL—metabolic syndrome X	1.53e-05	9.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.52e-05	9.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—APOA1—metabolic syndrome X	1.52e-05	9.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AGT—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AGT—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL5—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL5—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—INS—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—INS—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.52e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.52e-05	9.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.51e-05	9.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.51e-05	9.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.5e-05	8.93e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—NOS3—metabolic syndrome X	1.49e-05	8.87e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—APOE—metabolic syndrome X	1.49e-05	8.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—APOE—metabolic syndrome X	1.49e-05	8.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—LPL—metabolic syndrome X	1.48e-05	8.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—LPL—metabolic syndrome X	1.48e-05	8.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.48e-05	8.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—APOA1—metabolic syndrome X	1.47e-05	8.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—APOA1—metabolic syndrome X	1.47e-05	8.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.47e-05	8.75e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	1.46e-05	8.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.46e-05	8.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.46e-05	8.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.46e-05	8.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—SERPINE1—metabolic syndrome X	1.44e-05	8.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.44e-05	8.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.44e-05	8.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.44e-05	8.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.44e-05	8.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.43e-05	8.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.43e-05	8.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.42e-05	8.47e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.41e-05	8.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.41e-05	8.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.41e-05	8.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.41e-05	8.4e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.4e-05	8.36e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.4e-05	8.36e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.4e-05	8.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—SERPINE1—metabolic syndrome X	1.39e-05	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—SERPINE1—metabolic syndrome X	1.39e-05	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-05	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-05	8.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS3—metabolic syndrome X	1.38e-05	8.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.37e-05	8.18e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	1.36e-05	8.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.36e-05	8.11e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.35e-05	8.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.35e-05	8.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.34e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PPARG—metabolic syndrome X	1.34e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS3—metabolic syndrome X	1.33e-05	7.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS3—metabolic syndrome X	1.33e-05	7.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.32e-05	7.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.32e-05	7.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—INS—metabolic syndrome X	1.31e-05	7.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AGT—metabolic syndrome X	1.31e-05	7.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—AKT1—metabolic syndrome X	1.31e-05	7.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.3e-05	7.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.3e-05	7.74e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.3e-05	7.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.3e-05	7.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PPARG—metabolic syndrome X	1.3e-05	7.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PPARG—metabolic syndrome X	1.3e-05	7.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—APOE—metabolic syndrome X	1.29e-05	7.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—LEP—metabolic syndrome X	1.29e-05	7.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.28e-05	7.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.28e-05	7.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—metabolic syndrome X	1.28e-05	7.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—APOA1—metabolic syndrome X	1.27e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—INS—metabolic syndrome X	1.27e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—INS—metabolic syndrome X	1.27e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AGT—metabolic syndrome X	1.27e-05	7.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AGT—metabolic syndrome X	1.27e-05	7.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—AKT1—metabolic syndrome X	1.26e-05	7.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—AKT1—metabolic syndrome X	1.26e-05	7.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.26e-05	7.52e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.26e-05	7.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTGS2—metabolic syndrome X	1.26e-05	7.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.26e-05	7.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.25e-05	7.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—LEP—metabolic syndrome X	1.24e-05	7.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—LEP—metabolic syndrome X	1.24e-05	7.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOE—metabolic syndrome X	1.24e-05	7.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOE—metabolic syndrome X	1.24e-05	7.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—metabolic syndrome X	1.23e-05	7.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—metabolic syndrome X	1.23e-05	7.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOA1—metabolic syndrome X	1.23e-05	7.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOA1—metabolic syndrome X	1.23e-05	7.32e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.23e-05	7.3e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.23e-05	7.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—metabolic syndrome X	1.22e-05	7.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—metabolic syndrome X	1.22e-05	7.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ALB—metabolic syndrome X	1.2e-05	7.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	7.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.2e-05	7.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-05	7.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.19e-05	7.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.19e-05	7.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	1.18e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—AKT1—metabolic syndrome X	1.18e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	1.17e-05	6.99e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—AKT1—metabolic syndrome X	1.17e-05	6.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ALB—metabolic syndrome X	1.17e-05	6.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ALB—metabolic syndrome X	1.17e-05	6.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.17e-05	6.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	1.16e-05	6.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.16e-05	6.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—NOS3—metabolic syndrome X	1.15e-05	6.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IRS1—metabolic syndrome X	1.15e-05	6.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—AKT1—metabolic syndrome X	1.14e-05	6.78e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—AKT1—metabolic syndrome X	1.14e-05	6.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	1.14e-05	6.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—AKT1—metabolic syndrome X	1.13e-05	6.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—NOS3—metabolic syndrome X	1.11e-05	6.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—NOS3—metabolic syndrome X	1.11e-05	6.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.11e-05	6.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IRS1—metabolic syndrome X	1.11e-05	6.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IRS1—metabolic syndrome X	1.11e-05	6.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.11e-05	6.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—INS—metabolic syndrome X	1.1e-05	6.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	1.1e-05	6.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.1e-05	6.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—AKT1—metabolic syndrome X	1.09e-05	6.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—AKT1—metabolic syndrome X	1.09e-05	6.51e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.09e-05	6.5e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.09e-05	6.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-05	6.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—metabolic syndrome X	1.08e-05	6.44e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	1.08e-05	6.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	1.07e-05	6.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—INS—metabolic syndrome X	1.06e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—INS—metabolic syndrome X	1.06e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF1—metabolic syndrome X	1.06e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.06e-05	6.3e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.06e-05	6.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	1.06e-05	6.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—metabolic syndrome X	1.05e-05	6.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	6.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	6.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF1—metabolic syndrome X	1.03e-05	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF1—metabolic syndrome X	1.03e-05	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—metabolic syndrome X	1.02e-05	6.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—metabolic syndrome X	1.02e-05	6.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	1.02e-05	6.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	1.01e-05	6.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.01e-05	6.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	9.96e-06	5.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SERPINE1—metabolic syndrome X	9.77e-06	5.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.77e-06	5.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.74e-06	5.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NOS3—metabolic syndrome X	9.64e-06	5.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	9.59e-06	5.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NOS3—metabolic syndrome X	9.32e-06	5.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NOS3—metabolic syndrome X	9.32e-06	5.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	9.21e-06	5.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—metabolic syndrome X	9.1e-06	5.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	9.09e-06	5.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.05e-06	5.39e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOB—metabolic syndrome X	8.98e-06	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	8.91e-06	5.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.85e-06	5.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—metabolic syndrome X	8.8e-06	5.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—metabolic syndrome X	8.8e-06	5.24e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	8.73e-06	5.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	8.6e-06	5.12e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—LPL—metabolic syndrome X	8.57e-06	5.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	8.46e-06	5.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	8.22e-06	4.89e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CD36—metabolic syndrome X	8.14e-06	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—metabolic syndrome X	8.13e-06	4.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—metabolic syndrome X	7.86e-06	4.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—metabolic syndrome X	7.86e-06	4.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	7.68e-06	4.57e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	7.57e-06	4.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.52e-06	4.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—metabolic syndrome X	7.5e-06	4.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—metabolic syndrome X	7.43e-06	4.42e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—metabolic syndrome X	7.35e-06	4.38e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AGT—metabolic syndrome X	7.33e-06	4.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—metabolic syndrome X	7.25e-06	4.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—metabolic syndrome X	7.25e-06	4.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—metabolic syndrome X	7.19e-06	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—metabolic syndrome X	7.19e-06	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOE—metabolic syndrome X	7.18e-06	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	7.15e-06	4.26e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	7.1e-06	4.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	7.09e-06	4.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.98e-06	4.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	6.94e-06	4.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—metabolic syndrome X	6.86e-06	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—metabolic syndrome X	6.85e-06	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—metabolic syndrome X	6.85e-06	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	6.85e-06	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—metabolic syndrome X	6.63e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—metabolic syndrome X	6.63e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—metabolic syndrome X	6.63e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—metabolic syndrome X	6.63e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	6.48e-06	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	6.4e-06	3.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	6.38e-06	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—metabolic syndrome X	6.37e-06	3.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—metabolic syndrome X	6.33e-06	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	6.32e-06	3.76e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	6.26e-06	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—metabolic syndrome X	6.16e-06	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—metabolic syndrome X	6.16e-06	3.67e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—INS—metabolic syndrome X	6.14e-06	3.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—metabolic syndrome X	6.12e-06	3.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—metabolic syndrome X	6.12e-06	3.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	5.98e-06	3.56e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	5.88e-06	3.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	5.81e-06	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	5.66e-06	3.37e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—metabolic syndrome X	5.63e-06	3.35e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	5.38e-06	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—metabolic syndrome X	5.3e-06	3.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	5.26e-06	3.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	5.23e-06	3.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—metabolic syndrome X	5.13e-06	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—metabolic syndrome X	5.13e-06	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.92e-06	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.86e-06	2.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—metabolic syndrome X	4.8e-06	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—metabolic syndrome X	4.65e-06	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—metabolic syndrome X	4.65e-06	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—metabolic syndrome X	4.43e-06	2.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—metabolic syndrome X	4.29e-06	2.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—metabolic syndrome X	4.29e-06	2.55e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.47e-06	1.47e-05	CbGpPWpGaD
